Grenada vs Myanmar: Cause of death, by non-communicable diseases, ages 15-59
Grenada
56.8%
in 2021
Myanmar
56.4%
in 2021
Grenada rank
83rd
Myanmar rank
85th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Grenada
- Myanmar
How they compare
Grenada currently reports 56.8% against 56.4% in Myanmar, a difference of 0.4%.
Across all 6 years both countries report, Grenada has been ahead every year.
Grenada ranks 83rd and Myanmar ranks 85th of 185 countries.
Grenada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Grenada | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.1% | 51.2% | 21.9% | Grenada |
| 2010s | 76.3% | 60.7% | 15.6% | Grenada |
| 2020s | 67.4% | 61.1% | 6.3% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Grenada or Myanmar?
- Grenada, at 56.8% against 56.4% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Grenada and Myanmar?
- 0.4%, with Grenada ahead.
- How many years of comparable data are there for Grenada and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Grenada and Myanmar rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Grenada ranks 83rd and Myanmar ranks 85th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.